OMGA: Utang marang Ekuitas omegatherapeutics.com

Logo korporat perusahaan Omega Therapeutics (OMGA)

Omega Therapeutics (OMGA) is developing a precision gene control ecosystem via its OEC platform, establishing patent protection for B2B partnerships with pharmaceutical behemoths. This chart illustrates the total debt-to-equity ratio, which stands at 0.00, while operational processes are strictly regulated by FDA standards. Omega Therapeutics (OMGA) is also implementing epigenetic methods for correcting cellular instructions, enabling the treatment of pathologies without physically altering the DNA structure.

OMGA: Total Utang marang Modal Omega Therapeutics, Inc. 04.07.2022 - 08.03.2025

Rincian analitis perusahaan Omega Therapeutics

- rega saham lan konsensus proyeksi valuasi:
Rega saham Omega Therapeutics, Inc.|OMGA - Prakiraan gabungan firma investasi
- informasi kapitalisasi pasar:
Nilai pasar Omega Therapeutics|OMGA - Nilai Bisnis
- rincian nilai buku perusahaan:
Nilai Buku saben Saham Omega Therapeutics|OMGA - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku omegatherapeutics.com|OMGA - Aset Perusahaan
- statistik kawajiban utang lan likuiditas:
Utang marang Ekuitas Omega Therapeutics|OMGA - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Omega Therapeutics|OMGA - Utang kumulatif perusahaan|Utang-utang marang kapitalisasi buku Omega Therapeutics|OMGA - Tanggungan jangka dawa|Utang jangka cendhak perusahaan Omega Therapeutics|Indikator likuiditas cepet omegatherapeutics.com
- informasi bathi lan kelipatan valuasi:
OMGA - Bathi pungkasan
Analisis fundamental perusahaan:Omega Therapeutics, Inc., OMGA
Barang utama Omega Therapeutics Corp

To assess the financial stability of Omega Therapeutics (OMGA), it is critical to monitor the company's degree of dependence on external obligations. This ratio measures the share of total debt relative to equity, and the analysis of the debt-to-equity ratio confirms the biotech's high resilience to macroeconomic shocks, as the development of RNA medicine is not subject to market cyclicality.

Pesaing Omega Therapeutics (OMGA)

TEM (tempus.com) - Total Utang marang Modal|Rasio Utang marang Ekuitas QGEN (Qiagen NV)|Utang marang Ekuitas Ionis Pharma (IONS)|Repligen Inc. - Rasio Utang marang Ekuitas|Total Utang marang Modal RNA (Avidity Biosciences)|Total Utang marang Modal crisprtx.com CRSP|WGS - Utang marang Ekuitas|Utang marang Modal Ultragenyx Pharmaceutical Inc.|Beam Therapeutics Corp (BEAM) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Sarepta Corp|TWST (Twist Bioscience) - Total Utang marang Modal|Utang marang Modal 10xgenomics.com TXG|Total Utang marang Modal NTLA|Stoke Therapeutics Inc (STOK) - Rasio Utang marang Modal|Total Utang marang Modal BLFS (BioLife Corp)|Total Utang marang Modal Wave Pharma WVE|MAZE: Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi SION (sionnatx.com)|PRME (Prime Medicine) - Rasio Total Utang marang Ekuitas|TSHA: Utang Agregat marang Modal|QURE (uniQure Corp) - Total Utang marang Modal|MGTX: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal RGNX|SLDB - Utang marang Modal|Utang marang Ekuitas Ocugen OCGN|Rasio Kabeh Utang marang Dana Pribadi PACB|Benitec - Total Utang marang Modal|DSGN - Total Utang marang Modal|Rocket Pharmaceuticals (RCKT) - Utang marang Ekuitas|Utang Agregat marang Ekuitas FDMT (4dmoleculartherapeutics.com)|LXEO (Lexeo Therapeutics Inc.) - Total Utang marang Modal|Utang marang Modal Korro Bio, Inc KRRO|Rasio Total Utang marang Ekuitas EDIT (Editas)|Total Utang marang Modal Silence Therapeutics Corp (SLN)|ProQR Therapeutics - Rasio Total Utang marang Ekuitas|Utang Agregat marang Modal CDXS (Codexis Inc)|Sangamo Therapeutics, Inc. - Total Utang marang Modal|Koefisien Total Utang marang Modal Nautilus Biotechnology NAUT|MGX: Total Utang marang Modal|Rasio Total Utang marang Ekuitas Precision BioSciences Inc.|Utang marang Ekuitas Generation Bio Co|boundlessbio.com (BOLD) - Koefisien Total Utang marang Modal|Utang marang Ekuitas Exicure, Inc. (XCUR)|IMNN - Utang marang Modal|Utang marang Ekuitas Phio Pharmaceuticals Corp. PHIO|MBIO - Rasio Total Utang marang Ekuitas|TransCode - Total Utang marang Modal|Rasio Utang marang Modal Bionano Genomics, Inc. (BNGO)|APDN: Total Utang marang Modal|bluebird bio Inc. (BLUE) - Total Utang marang Modal|IPA (ImmunoPrecise Antibodies Ltd) - Total Utang marang Modal|Rasio Utang marang Ekuitas OMIC (Singular Genomics Corp)|Utang marang Ekuitas Regulus Therapeutics (RGLS)|syros.com - Rasio Utang marang Ekuitas|Total Utang marang Modal TBIO (Telesis Bio)|Total Utang marang Modal TRACON Pharmaceuticals Inc. TCON|UBX - Utang marang Ekuitas